Mac Macheta

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Dendritic cells in cancer immunology and immunotherapy

Autoimmune Complications of Chronic Lymphocytic Leukemia

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Detection of minimal residual disease

Biology and management of relapsed acute myeloid leukaemia

The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

Cancer as an evolutionary and ecological process

The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

Human dendritic cell subsets: an update

The Tumor Microenvironment Innately Modulates Cancer Progression

Hematological Problems in Pediatric Intensive Care

Prominent dyserythropoiesis in four cases of haemophagocytic lymphohistiocytosis

Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine.

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults